Article ; Online: A novel hemostatic delivery device for thrombin: biodegradable poly(D,L-lactide-co-glycolide) 50:50 microspheres.
Journal of biomedical materials research. Part A
2011 Volume 96, Issue 1, Page(s) 177–185
Abstract: Topical thrombins are locally active hemostatic agents that can be used to minimize blood loss during any surgery. The aim of this study was to design and investigate a thrombin-containing biodegradable hemostyptic device with an optimized drug release ... ...
Abstract | Topical thrombins are locally active hemostatic agents that can be used to minimize blood loss during any surgery. The aim of this study was to design and investigate a thrombin-containing biodegradable hemostyptic device with an optimized drug release profile to promote local blood clot formation. It is effective with ongoing systemic antithrombotic therapy and can be used in all types of bone-related surgery, for example, in dental surgery. Thrombin-loaded poly(D,L-lactide-co-glycolide) microspheres were synthesized by means of complex (w/o/w) emulsion evaporation method. The resulting enzyme activity of the serine-protease thrombin was verified by the specific chromogenic substrate S-2238. The thrombin release profile depended on four factors: (1) thrombin dosage, (2) polymer concentration in the o-phase, (3) phase quotient w1:0 in the primary emulsion, and (4) the addition of pore-introducing agents. A collagenous sponge containing thrombin-loaded microspheres by means of lyophilization was developed. The impact of several production factors of the (w1/o/w2) solvent evaporation method to optimize thrombin encapsulation, morphology of the spheres, and desired drug release profile have been investigated. The in vitro thrombin release was dependent on the polymer-to-oil phase ratio, the polymer concentration, and the type of solvent and polymer. The porosity of the spheres and release rate of the active agent were enhanced by increasing the inner aqueous w1 phase. With this study, a new biodegradable hemostyptic device could be verified and established for a potentially safe and locally controlled thrombin release to manage postsurgical hemorrhage in patients undergoing anticoagulant therapy. |
|||||
---|---|---|---|---|---|---|
MeSH term(s) | Absorbable Implants ; Biocompatible Materials/chemistry ; Biocompatible Materials/metabolism ; Drug Carriers/chemical synthesis ; Drug Carriers/chemistry ; Drug Carriers/metabolism ; Hemostatics/chemistry ; Hemostatics/metabolism ; Humans ; Hydrogen-Ion Concentration ; Lactic Acid/chemistry ; Materials Testing ; Microscopy, Electron, Scanning ; Microspheres ; Particle Size ; Polyglycolic Acid/chemistry ; Solvents ; Thrombin/chemistry ; Thrombin/metabolism | |||||
Chemical Substances | Biocompatible Materials ; Drug Carriers ; Hemostatics ; Solvents ; polylactic acid-polyglycolic acid copolymer ; Polyglycolic Acid (26009-03-0) ; Lactic Acid (33X04XA5AT) ; Thrombin (EC 3.4.21.5) | |||||
Language | English | |||||
Publishing date | 2011-01 | |||||
Publishing country | United States | |||||
Document type | Evaluation Studies ; Journal Article ; Research Support, Non-U.S. Gov't | |||||
ZDB-ID | 2099989-6 | |||||
ISSN | 1552-4965 ; 1549-3296 ; 0021-9304 | |||||
ISSN (online) | 1552-4965 | |||||
ISSN | 1549-3296 ; 0021-9304 | |||||
DOI | 10.1002/jbm.a.32970 | |||||
Shelf mark |
|
|||||
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6195: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.